Oruka Therapeutics, Inc. ORKA Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Oruka Therapeutics, Inc. (ORKA) reported comprehensive income (loss), net of tax, attributable to parent of -$32.85M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Oruka Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 56.7% year-over-year, from -$20.96M to -$32.85M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- Represents the total change in equity during the period from non-owner sources, including net income and other comprehensive income items. It provides a holistic view of the company's financial performance beyond standard net income.